Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$351K Buy
+74,921
New +$422K 0.01% 569
2025
Q4
Sell
-136,078
Closed -$626K 936
2025
Q3
$626K Buy
+136,078
New +$548K 0.01% 417
2025
Q2
Sell
-38,746
Closed -$114K 869
2025
Q1
$114K Buy
+38,746
New +$114K ﹤0.01% 734

Other funds holding RERE

Caxton Associates (UK)'s RERE Position: Q1 2026 in Review

Caxton Associates (UK) opened a new position in ATRenew (RERE) in Q1 2026: 74,921 shares worth $351K. The stake represents 0.01% of the portfolio and ranks #569 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in RERE as recently as Q3 2025.

Caxton Associates (UK) first reported a position in RERE in Q1 2025 and has held it in 3 quarters since. The position peaked at $626K in Q3 2025. 82 funds tracked by Wall St. Rank hold RERE as of Q1 2026.

  • Caxton Associates (UK) held 74,921 shares of ATRenew worth $351K as of Q1 2026.
  • ATRenew was a new Caxton Associates (UK) position in Q1 2026.
  • ATRenew made up 0.01% of Caxton Associates (UK)'s portfolio in Q1 2026, its #569 holding.
  • Caxton Associates (UK) first reported a position in ATRenew in Q1 2025 and has held it in 3 quarters since.
  • Caxton Associates (UK)'s ATRenew position peaked at $626K in Q3 2025.
  • 82 funds tracked by Wall St. Rank held ATRenew as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.